Boston Advisors’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $997K | Buy |
64,186
+24,416
| +61% | +$379K | 0.05% | 387 |
|
|
2019
Q2 | $807K | Hold |
39,770
| – | – | 0.04% | 408 |
|
|
2019
Q1 | $699K | Sell |
39,770
-23,555
| -37% | -$414K | 0.04% | 409 |
|
|
2018
Q4 | $812K | Buy |
63,325
+6,565
| +12% | +$84.2K | 0.05% | 363 |
|
|
2018
Q3 | $925K | Sell |
56,760
-1,270
| -2% | -$20.7K | 0.04% | 391 |
|
|
2018
Q2 | $658K | Buy |
58,030
+6,570
| +13% | +$74.5K | 0.02% | 448 |
|
|
2018
Q1 | $502K | Buy |
+51,460
| New | +$502K | 0.01% | 495 |
|